Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance (Q39828227)

15 September 2017

title

Upregulation of glycolytic enzymes in proteins secreted from human colon cancer cells with 5-fluorouracil resistance (English)

1 reference

15 September 2017

1 reference

1 reference

7

Jae-Gahb Park

1 reference

15 September 2017

Young-Kyoung Shin

1

1 reference

15 September 2017

Byong Chul Yoo

2

1 reference

15 September 2017

Yong Sang Hong

3

1 reference

15 September 2017

Hee Jin Chang

4

1 reference

15 September 2017

Kyung Hae Jung

5

1 reference

15 September 2017

Seung-Yong Jeong

6

1 reference

15 September 2017

publication date

1 June 2009

1 reference

15 September 2017

1 reference

15 September 2017

volume

30

1 reference

15 September 2017

issue

12

1 reference

15 September 2017

page(s)

2182-2192

1 reference

Proteomic analysis of dendritic cell-derived exosomes: a secreted subcellular compartment distinct from apoptotic vesicles

15 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

Tumor type M2 pyruvate kinase expression in gastric cancer, colorectal cancer and controls

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

5-Fluorouracil: mechanisms of action and clinical strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Predicting the outcome of chemotherapy for colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Tumor suppressor Smad4 mediates downregulation of the anti-adhesive invasion-promoting matricellular protein SPARC: Landscaping activity of Smad4 as revealed by a "secretome" analysis.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

A novel strategy for quantitative proteomics using isotope-coded protein labels

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Down-regulation of mitochondrial F1F0-ATP synthase in human colon cancer cells with induced 5-fluorouracil resistance

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Reporting results of cancer treatment

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Secretory protein enrichment and analysis: an optimized approach applied on cancer cell lines using 2D LC-MS/MS.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Identification and proteomic profiling of exosomes in human urine

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Intestinal epithelial cells secrete exosome-like vesicles

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Identification of collapsin response mediator protein-2 as a potential marker of colorectal carcinoma by comparative analysis of cancer cell secretomes

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

On the Origin of Cancer Cells

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Proteomic analysis of colorectal cancer reveals alterations in metabolic pathways: mechanism of tumorigenesis.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Proteomic analysis of hyperoxia-induced responses in the human choriocarcinoma cell line JEG-3.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Pyruvate kinase type M2 and its role in tumor growth and spreading

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Tumor M2-pyruvate kinase, a new metabolic marker for pancreatic cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Tumor type M2-pyruvate-kinase levels in pleural fluid versus plasma in cancer patients: a further tool to define the need for invasive procedures

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Lactate Dehydrogenase 5 Expression in Operable Colorectal Cancer: Strong Association With Survival and Activated Vascular Endothelial Growth Factor Pathway—A Report of the Tumour Angiogenesis Research Group

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Serum lactate dehydrogenase level is a prognostic factor in patients with locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Prognostic factors for survival in patients with advanced oesophageal cancer treated with cisplatin-based combination chemotherapy

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Lactate dehydrogenase as a prognostic factor for survival time of terminally ill cancer patients: a preliminary study

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Elevation of serum l-lactate dehydrogenase B correlated with the clinical stage of lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Lactate dehydrogenase 5 (LDH5) relates to up-regulated hypoxia inducible factor pathway and metastasis in colorectal cancer

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Serum lactate dehydrogenase levels and glycolysis significantly correlate with tumor VEGFA and VEGFR expression in metastatic CRC patients

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Diagnostic and prognostic value of plasma tumor M2 pyruvate kinase in periampullary cancer: evidence for a novel biological marker of adverse prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Tumor type M2 pyruvate kinase expression in metastatic renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1002%2FELPS.200800806

7 January 2021

Identifiers

DOI

10.1002/ELPS.200800806

1 reference

15 September 2017

1 reference